Thesis Abstract

Abstract
The emergence of antimicrobial resistance poses a significant challenge to public health worldwide, necessitating the exploration of alternative treatment options. This research project focuses on investigating the antimicrobial properties of natural plant extracts against pathogenic bacteria. The study aims to evaluate the potential of selected plant extracts in inhibiting the growth of pathogenic bacteria through a series of laboratory experiments. The research begins with a comprehensive review of the existing literature on antimicrobial properties of plant extracts, highlighting previous studies and their findings. The methodology chapter outlines the experimental design, including the selection of plant extracts, bacterial strains, and the procedures for testing antimicrobial activity. The results of the study are discussed in detail in the findings chapter, presenting the effectiveness of plant extracts in inhibiting the growth of pathogenic bacteria. The significance of this research lies in the potential discovery of novel antimicrobial agents from natural sources, which could provide safer and more sustainable alternatives to conventional antibiotics. The findings of this study may contribute to the development of new antimicrobial therapies and help combat the rising threat of antimicrobial resistance. In conclusion, this research project serves as a foundational investigation into the antimicrobial properties of natural plant extracts against pathogenic bacteria. The results of this study have the potential to impact public health by providing new insights into alternative treatment options for bacterial infections. Further research in this area is warranted to fully explore the therapeutic potential of plant-derived antimicrobial agents.

Thesis Overview

The project titled "Investigation of the antimicrobial properties of natural plant extracts against pathogenic bacteria" aims to explore the potential of natural plant extracts as alternative antimicrobial agents against pathogenic bacteria. The rise of antibiotic resistance poses a significant threat to public health, making it crucial to search for new antimicrobial compounds. Natural plant extracts have long been used in traditional medicine for their therapeutic properties, and research has shown that many plant compounds possess antimicrobial activity. This research project will begin with a comprehensive literature review to gather existing knowledge on the antimicrobial properties of natural plant extracts. This review will cover studies on the mechanisms of action of plant compounds against bacteria, as well as their efficacy and safety profiles. By synthesizing this information, the project aims to identify gaps in the current understanding and establish a solid foundation for the experimental phase. The experimental phase of the project will involve the extraction of bioactive compounds from selected plant species known for their antimicrobial properties. These extracts will then be tested against a panel of pathogenic bacteria in vitro to evaluate their antimicrobial activity. The project will also investigate the mechanisms of action of the plant extracts, such as their ability to disrupt bacterial cell membranes or inhibit essential enzymes. In addition to assessing the antimicrobial efficacy of the plant extracts, the project will also explore their potential synergistic effects with conventional antibiotics. Combining plant extracts with antibiotics has the potential to enhance the antimicrobial activity of the drugs and reduce the development of antibiotic resistance. The findings of this research project have the potential to contribute to the development of new antimicrobial agents for combating pathogenic bacteria. By harnessing the antimicrobial properties of natural plant extracts, this project aims to provide valuable insights into alternative treatment options for infectious diseases. Ultimately, the goal is to bridge the gap between traditional herbal remedies and modern medicine, paving the way for the discovery of novel antimicrobial therapies.